Overview

Safety and Tolerability of LIM-0705 in Healthy Male Subjects

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
LIM-0705 dosed separately and in combination with tacrolimus will be safe and well tolerated.
Phase:
Phase 1
Details
Lead Sponsor:
Limerick BioPharma
Treatments:
Tacrolimus